| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Beverley J Hunt | |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 847-859 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Bleeding and coagulopathies in critical care | |
| P478 | volume | 370 |
| Q36068943 | 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. |
| Q61796252 | A Novel Treatment for Massive Hemorrhage after Maternal Trauma in Pregnancy |
| Q38579254 | A critical appraisal of point-of-care coagulation testing in critically ill patients |
| Q88365528 | A summary of the Japan septic disseminated intravascular coagulation study |
| Q27327667 | A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis |
| Q90532314 | Acute myeloid leukemia with severe coagulation disorder and concomitant central nervous system bleeding - a clinical diagnostic case report |
| Q41694620 | Adjuvant treatment of sepsis: what is known? |
| Q34649446 | Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group. |
| Q64892718 | Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. |
| Q38423870 | Alcohol effects on cardiac function |
| Q47406040 | An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis |
| Q33424238 | An instructive case of presumed brown snake (Pseudonaja spp.) envenoming |
| Q92639094 | Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery |
| Q38457021 | Anticoagulant modulation of inflammation in severe sepsis |
| Q38209738 | Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan |
| Q35951277 | Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational Study |
| Q64099432 | Assessment of agreement and interchangeability between the TEG5000 and TEG6S thromboelastography haemostasis analysers: a prospective validation study |
| Q92081837 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |
| Q33419886 | Catastrophic APS in the context of other thrombotic microangiopathies |
| Q91938814 | Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation |
| Q40612754 | Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study |
| Q31136660 | Diagnosis and Management of Acute Intracerebral Hemorrhage |
| Q34446478 | Ebola virus disease: an update for anesthesiologists and intensivists |
| Q35107098 | Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation |
| Q58750602 | Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study |
| Q35891985 | Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database |
| Q33419474 | Hemostatic abnormalities in critically ill patients |
| Q33419312 | Hospital-acquired thrombocytopenia |
| Q36474737 | Ilio-psoas hematoma in the intensive care unit: a multicentric study |
| Q47126929 | Immunohaemostasis: a new view on haemostasis during sepsis |
| Q61448465 | Increased urokinase and consumption of α -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay |
| Q51332285 | Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis? |
| Q57824692 | Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure |
| Q38366956 | Management of cardiogenic shock |
| Q59789406 | Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013 |
| Q39173761 | Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders |
| Q52668975 | Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study. |
| Q27013790 | PAMPs and DAMPs as triggers for DIC |
| Q38986619 | Plasma exchange in the intensive care unit: Technical aspects and complications. |
| Q24187500 | Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation |
| Q36137840 | Plasma transfusions prior to insertion of central lines for people with abnormal coagulation |
| Q94328375 | Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation |
| Q45872457 | Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation. |
| Q48273959 | Post-partum haemorrhage and tranexamic acid: a global issue |
| Q28076449 | Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis |
| Q42316665 | Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies |
| Q90045442 | Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy |
| Q37539104 | Quality Assessment of Established and Emerging Blood Components for Transfusion |
| Q64886128 | Recurrent Gastrointestinal Bleeding from Dieulafoy's Lesions in a Patient with Type 1 von Willebrand Disease: A Rare Association. |
| Q53250993 | Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis? |
| Q88477279 | Ten things ICU specialists need to know about direct oral anticoagulants (DOACs) |
| Q28830861 | The European Hematology Association Roadmap for European Hematology Research: a consensus document |
| Q33419972 | The challenge of bleeding in antiphospholipid antibody-positive patients |
| Q36198065 | The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study |
| Q33418970 | The management of abnormal haemostasis in the ICU. |
| Q38612382 | The role of heparin in sepsis: much more than just an anticoagulant. |
| Q30583254 | Therapeutic translation in acute kidney injury: the epithelial/endothelial axis |
| Q64248267 | Thrombocytopenia in the intensive care unit |
| Q33438579 | Thromboelastometry analysis of thrombocytopenic dengue patients: a cross-sectional study |
| Q24187024 | Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia |
| Q43163829 | Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation |
Search more.